Cara Therapeutics, Inc. (CARA)
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
29 Jun 2017
Slagel Dean
Director
Cara Therapeutics, Inc.
(CARA)
1,085,200-18%
250,000
$25.87
$6,468,563.50
Home